Raycaster

Raycaster revolutionizes biopharmaceutical document management by integrating regulatory data with scientific developments. Key capabilities include: • Unifying protocols, reports, and quality documents • Cross-referencing regulatory requirements and scientific findings • Automatic drafting of specialized biopharma documents • Impact analysis for proposed changes across documentation • Ensuring consistency and compliance throughout drug development This platform reads and connects information across diverse documents such as CSRs, Module 2/3 sections, SOPs, and vital guidance. It allows users to ask regulatory questions and instantly receive detailed answers, complete with citations to exact paragraphs and identification of regional requirements or potential gaps. This capability empowers teams to perform regulatory research with unprecedented confidence and accuracy. Raycaster also significantly speeds up document creation by drafting protocols, amendments, IBs, CSRs, narratives, and key Module 2/3 sections based on existing templates and data. Writers can focus on reviewing and refining content rather than starting from scratch. Furthermore, when an endpoint, limit, or process parameter is adjusted, the platform identifies every impacted document, traces its effects across the entire dossier, and suggests aligned updates. This ensures that all related protocols, reports, and modules remain synchronized as the scientific understanding evolves. Designed for clinical, CMC, regulatory, and quality teams, Raycaster facilitates faster document submission and significantly reduces rework. It adapts to existing workflows for IND submission and lifecycle management, empowering teams to move molecules forward efficiently while maintaining stringent control over documentation and compliance.